申请人:Infinity Pharmaceuticals, Inc.
公开号:EP2399584A1
公开(公告)日:2011-12-28
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
本发明提供了式(I)、(II)或(III)所包含的化合物及其药物组合物。本发明还提供了通过向有需要的患者施用治疗有效量的所提供的式(I)、(II)或(III)化合物或其药物组合物来治疗FAAH介导的疾病、紊乱或病症的方法。此外,本发明还提供了通过向有需要的患者施用治疗有效量的式(I)、(II)或(III)化合物或其药物组合物来抑制患者体内FAAH的方法。